Ekso Bionics (EKSO) insider Daniel Asher details ownership stake

Rhea-AI Filing Summary

Daniel Asher has filed an initial Form 3 as a 10% owner of Ekso Bionics Holdings, Inc.. He reports beneficial ownership of Ekso common stock and a significant preferred position that can convert into additional common shares.

Asher directly owns 165,000 shares of common stock and indirectly owns 156,763 common shares through DBA Trading, LLC, where he is the beneficial owner with voting and dispositive power. He also indirectly holds Convertible Preferred Stock that is exercisable into 355,961 shares of common stock at a conversion price of $8.22 per share through the Daniel Asher Descendants Trust, where he is the grantor and controls voting and dispositive power.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ASHER DANIEL

(Last) (First) (Middle)

1011 LAKE ST

SUITE 311

(Street)

OAK PARK IL 60301

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/22/2026

3. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	165,000	D
Common Stock	156,763	I	by DBA Trading, LLC(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible Preferred Stock	01/22/2026	(3)	Common Stock	355,961	$8.22	I	By Daniel Asher Descendants Trust(2)

Explanation of Responses:

1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.

2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.

3. None

	Daniel Asher	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Daniel Asher’s Form 3 filing for EKSO show?

The Form 3 shows that Daniel Asher is a 10% owner of Ekso Bionics. He reports direct and indirect ownership of common stock and convertible preferred stock that can be turned into additional common shares, outlining his total beneficial stake at the reporting date.

How many EKSO common shares does Daniel Asher directly own?

Daniel Asher directly owns 165,000 shares of Ekso Bionics common stock. This position is reported as directly held, separate from additional common shares and convertible preferred stock that he controls indirectly through DBA Trading, LLC and the Daniel Asher Descendants Trust entities.

What EKSO shares are held indirectly through DBA Trading, LLC?

DBA Trading, LLC holds 156,763 Ekso Bionics common shares indirectly for Daniel Asher. He is described as the beneficial owner of DBA Trading, LLC and is deemed to control voting and dispositive power over these shares, making them part of his reported beneficial ownership.

What is the Daniel Asher Descendants Trust’s EKSO position?

The Daniel Asher Descendants Trust holds Ekso Bionics convertible preferred stock. This security is exercisable into 355,961 shares of common stock at a conversion price of $8.22, and Daniel Asher, as grantor, is deemed to control voting and dispositive power over the trust’s holdings.

What type of derivative security linked to EKSO does Daniel Asher report?

He reports holding Ekso Bionics Convertible Preferred Stock as a derivative security. It is exercisable into 355,961 shares of common stock at a stated conversion price of $8.22 per share, and is reported as indirectly owned through the Daniel Asher Descendants Trust structure.

Why is Daniel Asher considered a 10% owner of EKSO?

Combining his direct common shares, indirect common shares through DBA Trading, LLC, and the common stock underlying his convertible preferred holdings, Daniel Asher’s beneficial ownership reaches at least 10%. This threshold status is explicitly indicated by the Form 3’s 10% owner designation.